- Research article
- Open Access
- Open Peer Review
Cardiovascular disease and air pollution in Scotland: no association or insufficient data and study design?
© Willocks et al.; licensee BioMed Central Ltd. 2012
- Received: 9 November 2011
- Accepted: 22 March 2012
- Published: 22 March 2012
Coronary heart disease and stroke are leading causes of mortality and ill health in Scotland, and clear associations have been found in previous studies between air pollution and cardiovascular disease. This study aimed to use routinely available data to examine whether there is any evidence of an association between short-term exposure to particulate matter (measured as PM10, particles less than 10 micrograms per cubic metre) and hospital admissions due to cardiovascular disease, in the two largest cities in Scotland during the years 2000 to 2006.
The study utilised an ecological time series design, and the analysis was based on overdispersed Poisson log-linear models.
No consistent associations were found between PM10 concentrations and cardiovascular hospital admissions in either of the cities studied, as all of the estimated relative risks were close to one, and all but one of the associated 95% confidence intervals contained the null risk of one.
This study suggests that in small cities, where air quality is relatively good, then either PM10 concentrations have no effect on cardiovascular ill health, or that the routinely available data and the corresponding study design are not sufficient to detect an association.
- National Health Service
- PM10 Concentration
- Daily Maximum Temperature
- Pollution Data
- Time Series Study
The detrimental effects of air pollution on human health came to public prominence in the mid 1900s, as a result of high pollution episodes in the Meuse valley, Belgium (1930), Donora, Pennsylvania (1948), and London, England (1952). The latter was associated with more than 3,000 excess deaths , and was the catalyst for legislation such as the UK Clean Air Act in 1956. Since then, a large number of studies have investigated the health risks from air pollution, and found consistent associations between components of ambient air pollution and measures of ill health. Numerous health endpoints have been considered in such studies, with the most common being mortality  and morbidity  from respiratory  and cardiovascular  disease. A number of different pollutants have also been considered in such studies, including, carbon monoxide , ozone  and both coarse  and fine  particulate matter. These studies have investigated the effects of both long-term  and  and short-term  and  pollution exposure, with the latter typically utilising an ecological time series design. Such time series studies make use of routinely available health and pollution data, and are thus the most common study design because they are inexpensive to conduct.
Studies such as those highlighted above provide evidence for the creation of air pollution legislation and guidelines, with examples in the UK being the Clean Air Act (1993) and the Air Quality Strategy (2007). In recent times, the conduit for such studies to effect UK legislation has been the independent Committee On the Medical Effects of Air Pollution (COMEAP), which informs governmental policy by critiquing the evidence provided by such studies. However, surprisingly few of these studies quantify the effects of pollution in the UK, with the majority being based in the USA  and , mainland Europe  and  or Asia  and . As a result, COMEAP has been forced to base its recommendations to government on studies from further afield, particularly the USA. The transportation of evidence from one continent to another has its own problems (as acknowledged by COMEAP), and suggests that more studies are required to further assess the effects of air pollution in the UK. Furthermore, the studies that have been conducted in the UK have been predominantly based in London  and , with relatively few assessing the health impact of air pollution in Wales, Northern Ireland or Scotland.
In Scotland, studies estimating the short-term effects of pollution are limited to  and . The short-term study  was based in Edinburgh, and investigated the effects of multiple pollutants, including nitrogen dioxide, ozone and particulate matter, on multiple health end-points between 1981 and 1995. The results from this study were largely negative, consistently showing no relationship between pollution and ill health. Study  extended study  to Aberdeen, Edinburgh and Glasgow, the three largest cities in Scotland, and performed a meta-analysis to give overall results for urban Scotland. Their study was based on data from 1981 to 2001, and also failed to find any consistent associations.
Therefore the aim of this paper is two-fold. Firstly, we extend  and  using more recent data (2000 to 2006), allowing us to add to the limited body of evidence about the effects of air pollution on health in Scotland, as well as in the UK more generally. Secondly, we provide a critique of the challenges inherent in conducting ecological time series studies of this type, particularly the appropriateness of using routinely available health and pollution data for this purpose in small to medium sized cities. Our study focuses on coronary heart disease (CHD) and stroke as the health outcomes, because they are leading causes of death and ill health in Scotland, and are clinical and public health priorities for NHS Scotland. The pollutant we consider is coarse particulate matter (PM10, particles less than 10 micrograms per cubic metre), because it is the pollutant most often linked to health, and because measurements of finer particulate matter (PM2.5 and PM1) are not available.
In this study we focus on the two largest cities in Scotland, Edinburgh and Glasgow, which have populations of around 486,000 and 593,000 respectively. Daily counts of the numbers of acute hospital admissions with a primary diagnosis of CHD (ICD 10 codes I20-I25) or stroke (ICD 10 codes I61, I63 and I64) were obtained for both cities, for the seven year period spanning 2000 to 2006. This dataset (aggregated and non-disclosive) was requested from the Information Services Division (ISD) of the National Health Service (NHS) in Scotland, who provided it for the purposes of this study. Daily mean PM10 concentrations are measured by a network of monitors located throughout Scotland, and the corresponding data were downloaded from the Scottish Air Quality website (http://www.scottishairquality.co.uk). These data comprise measurements from three centrally sited monitors in Edinburgh and six from Glasgow, although only one and two of these monitors respectively have measurements for the entire time period (the rest did not start measuring until 2005).
An important confounding variable in existing studies of this type is temperature, and daily maximum temperatures (in Celsius) were obtained from five centrally sited monitors (three in Edinburgh and two in Glasgow) from the British Atmospheric Data Centre. In addition, daily minimum temperatures were also available at the same sites, but the results from the statistical models were invariant to choice of minimum or maximum temperature. In common with the air pollution data, the average value across all sites within a city was calculated to produce a single representative measure for each day. Finally, as our research uses routinely collected data at the ecological (population) rather than the individual level, it conforms to the Helsinki Declaration, and does not require approval from an ethics committee.
The statistical methods we adopt are similar to those used in the National Morbidity Mortality and Air Pollution Study (NMMAPS),  and the Air Pollution and Health a European Approach 2 study (APHEA2), , which are large multi-city studies based in the USA  and Europe  respectively. The daily admissions counts in each city are modelled by overdispersed log-linear Poisson models, which do not make the restrictive assumption that the mean and variance of each observation is the same. Instead, the variance is assumed to be proportional to the mean, because overdispersion (having a variance greater than the mean) is commonly seen in health count data of this type. The covariates are linked to the expected value of the response by a natural log link function, and the models were fitted using maximum likelihood methods in the statistical package R.
The covariates used to model the daily admissions counts included daily mean PM10, daily maximum temperature, a day of the week effect, and a non-linear time trend. The pollution data were lagged by k days relative to the admissions data, to ensure that the exposure occurred before the response. Lags of between zero and five days are typically considered in studies of this type, and the results for these lags are presented in the next section. Both linear and quadratic relationships were considered between the response variable and the maximum temperature covariate, because previous studies have shown evidence of a U-shaped relationship, with increased risks being observed on very cold and very hot days. However, a linear relationship is appropriate here for both cities, which is likely to be because Scotland rarely has days hot enough to cause any adverse health effects.
Finally, we included a non-linear seasonal time trend modelled by a natural cubic spline, because this was the approach adopted in the NMMAPS  and APHEA2  studies. The smoothness of this estimated trend is controlled by its degrees of freedom, and a value of 21 is used for both cities because it is the smallest value that removed all the trend and short-term correlation from the residuals. The presence or absence of the latter was assessed by examining the residual autocorrelation and partial autocorrelation functions, which suggested that the assumption of independence was valid. Finally, the estimated overdispersion parameters from the log-linear Poisson models were 1.01 (Edinburgh) and 0.98 (Glasgow) respectively, suggesting that for these data the Poisson assumption of equal means and variances was adequate.
Relative risks (RR) and 95% confidence intervals (CI) for an increase of 10 micrograms per cubic metre in PM 10 in Edinburgh and Glasgow at lags zero to five
To determine the robustness of these results, a number of supplementary analyses were undertaken. For these supplementary analyses the study design was aggregated to the weekly rather than the daily scale, as the null results may have been due to the lack of variation (small numbers) in the daily hospital admissions series. Similar Poisson regression models to those described in the previous section were applied to the weekly admissions data, and the relative risks for lags of zero and one week were calculated. The estimated relative risks and 95% confidence intervals for the two cities were 1.0094 (0.987, 1.0410) (Edinburgh) and 1.0034 (0.9885, 1.0185) (Glasgow) at lag zero, and 1.0074 (0.9769, 1.0388) (Edinburgh) and 0.9885 (0.9729, 1.0043) (Glasgow) at lag one, which again suggests that PM10 concentrations have no effect on cardiovascular hospital admissions in Scotland. The increased widths of the confidence intervals, relative to those calculated for the daily analyses, are due to a decrease in the numbers of data points after aggregation to the weekly level (2,557 compared with 365). Finally, we also assessed the effects of PM10 on cardiovascular mortality, and again found no consistent significant associations.
The main finding of this study is that there was no association between PM10 concentrations and cardiovascular hospital admissions in urban Scotland between 2000 and 2006. This result is consistent with the earlier studies  and  in Scotland, but goes against the majority of the published literature (see for example  and , especially the systematic review of the existing evidence published by the COMEAP in 2006 . This in turn raises the question of why no association was found, and there are a number of possible explanations.
The first is that PM10 concentrations may not have a detrimental effect on cardiovascular ill health in urban Scotland during the time period considered by this study. The lack of such an association could be because the level of PM10 was too low to have an effect on cardiovascular ill health, as the concentrations observed are well below the limits set by the UK air quality strategy in 2007. In addition, PM10 concentrations have fallen by around 50% in the UK between 1990 and 2006 (http://www.scotland.gov.uk/Topics/Statistics/Browse/Environment/TrendPM10), and many of the existing studies that found positive associations predate such improvements in air quality. For example, in the present study the median concentrations observed in Edinburgh and Glasgow were 20 μg/m3 and 22.5 μg/m3 respectively, which are substantially lower than in five of the eight cities studied in  during the 1990s (the average concentrations in μg/m3 in these five cities were 28, 39, 51, 52, 56).
A second explanation is that the air pollution monitoring network in Scotland may not be sufficient to accurately characterise the spatial pattern in PM10 concentrations across the two cities, thus potentially leading to errors in the daily exposure estimates. Such errors may occur because the pollution network measures ambient (outdoor) concentrations from a small number of centrally sited monitors, some of which are located next to busy roads. Therefore the concentrations recorded by these monitors are unlikely to be representative of the levels of pollution to which the population are actually exposed. A number of statistical approaches have been proposed to tackle this problem, including the use of exposure simulators  and measurement error models . However, such approaches are not a substitute for improved data collection, and different monitoring strategies may be required for air pollution in the future.
A third possibility to explain the null results found in this study is that PM10 is not the most appropriate exposure measure, because it contains relatively coarse particles that cannot travel deep into the lungs. In fact, recent evidence (see for example  and ) has shown that smaller particles, such as PM2.5, PM1 and ultra fine particles, are likely to be more toxic to human health, in part because they can travel further into the lungs. However, as already discussed, air pollution monitoring in Scotland was relatively sparse during the study period, and PM2.5 concentrations were not measured consistently until early 2008 in Edinburgh and late 2004 in Glasgow.
An alternative statistical explanation of our results may be that the study design did not provide enough statistical power to detect a pollution-health relationship. The choice of a time series design for this study was made for two reasons, comparability with existing research, and the routine availability of the required data. The latter is likely to be one of the major reasons why time series designs make up the largest proportion of air pollution and health studies, because they are fast and inexpensive to conduct. However, for this study design to have enough statistical power to detect an effect, both the exposure and the response series need to have sufficient levels of day-to-day variation. For the Scottish data analysed here this may not have been the case, as the levels of variation in both series were relatively low. The inter-quartile ranges for the daily cardiovascular disease counts ranged from 4 to 8 cases per day in Edinburgh, compared with between 8 and 13 cases per day in Glasgow. The variations in the daily PM10 concentrations were also relatively small, with inter-quartile ranges of between 16.0 and 26.0 in Edinburgh, compared with between 17.0 and 30.5 in Glasgow.
These low levels of day-to-day variation in both series may have led to a lack of statistical power in the study, which in turn may have contributed to the null associations observed here. This suggests that such routinely available data may not be sufficient for estimating the association between air pollution and ill health in small to medium sized cities such as Glasgow and Edinburgh, where the levels of day-to-day variation in both pollution and ill health are relatively small. Therefore, in the future alternative study designs with more statistical power may be required to accurately estimate the effects of air pollution on human health in Scotland. One possibility would be conduct a cohort study similar to  and , although such a study would require individual level measurements of health and pollution exposure, which would be expensive to obtain. Such an individual level study would also require data on confounding factors such as smoking status, which are not required in ecological time series studies because the distribution of such covariates across the population under study is unlikely to change on a day-to-day basis.
This study suggests that in small cities where air quality is relatively good, then: either there is no relationship between concentrations of PM10 and cardiovascular ill health; or that time series studies lack the necessary statistical power to detect an effect and hence may not be an appropriate study design in this context.
We wish to acknowledge Carole Morris’s support in data collection. We also would like to thank the editor and two referees for their helpful suggestions, which have improved the focus and content of this paper.
This work was supported by NHS Scotland, and the work of Abita Bhaskar was funded by ISD Scotland.
- Ministry of Public Health: Mortality and Morbidity during the London Smog of December 1952. The Stationery Office. 1952, : -.Google Scholar
- Dominici F, Samet J, Zeger S: Combining evidence on air pollution and daily mortality from the 20 largest US cities: A hierarchical modelling strategy. Journal of the Royal Statistical Society Series A. 2000, 162: 263-302.View ArticleGoogle Scholar
- Dominici F, Peng R, Bell M, Pham L, McDermott A, Zeger S, Samet J: Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. J Am Med Assoc. 2006, 295: 1127-1134. 10.1001/jama.295.10.1127.View ArticleGoogle Scholar
- Atkinson R, Anderson R, Sunyer J, Ayres J, Baccini M, Vonk J, Boumghar A, Forastiere F, Forsberg B, Touloumi G, Schwartz J, Katsouyanni K: Acute effects of particulate air pollution on respiratory admissions: results from the APHEA 2 Project. Am J Respir Crit Care Med. 2001, 164: 1860-1866.View ArticlePubMedGoogle Scholar
- Sun Q, Hong X, Wold L: Cardiovascular effects of ambient particulate air pollution exposure. Circulation. 2010, 121: 2755-2765. 10.1161/CIRCULATIONAHA.109.893461.View ArticlePubMedPubMed CentralGoogle Scholar
- Bell M, Peng R, Dominici F, Samet J: Emergency hospital admissions for cardiovascular diseases and ambient levels of carbon monoxide. Circulation. 2009, 120: 949-955. 10.1161/CIRCULATIONAHA.109.851113.View ArticlePubMedPubMed CentralGoogle Scholar
- Ji M, Cohan D, Bell M: Meta-analysis of the association between short-term exposure to ambient ozone and respiratory hospital admissions. Environ Res Lett. 2011, 6: 024006-10.1088/1748-9326/6/2/024006.View ArticlePubMedPubMed CentralGoogle Scholar
- Peng R, Chang H, Bell M, McDermott A, Zeger S, Samet J, Dominici F: Coarse particulate matter air pollution and hospital admissions for cardiovascular and respiratory diseases among medicare patients. J Am Med Assoc. 2008, 299: 2172-2179. 10.1001/jama.299.18.2172.View ArticleGoogle Scholar
- Miller K, Siscovick D, Sheppard L, Shepherd K, Sullivan J, Anderson G, Kaufman J: Long-term exposure to air pollution and incidence of cardiovascular events in women. N Eng J Med. 2007, 356: 447-458. 10.1056/NEJMoa054409.View ArticleGoogle Scholar
- Dockery DW, Pope CA, Xu X, Spengler J, Ware J, Fay M, Ferris B, Speizer F: An association between air pollution and mortality in six US cities. N Eng J Med. 1993, 329: 1753-1759. 10.1056/NEJM199312093292401.View ArticleGoogle Scholar
- Le Tertre A, Medina S, Samoli E, Forsberg B, Michelozzi P, Boumghar A, Vonk J, Bellini A, Atkinson R, Ayres J, Sunyer J, Schwartz J, Katsouyanni K: Short-term effects of particulate air pollution on cardiovascular diseases in eight European cities. J Epidemiol Community Health. 2002, 56: 773-779. 10.1136/jech.56.10.773.View ArticlePubMedPubMed CentralGoogle Scholar
- Bell M, Ebisu K, Peng R, Walker J, Samet J, Zeger S, Dominici F: Seasonal and regional short-term effects of fine particles on hospital admissions in 202 US Counties, 1999–2005. American Journal of Epidemology. 2008, 168: 1301-1310. 10.1093/aje/kwn252.View ArticleGoogle Scholar
- Schwartz J, Morris R: Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am J Epidemiol. 1995, 142: 23-35.PubMedGoogle Scholar
- Belleudi V, Faustini A, Stafoggia M, Cattani G, Marconi A, Perucci C, Forastiere F: Impact of fine and ultrafine particles on emergency hospital admissions for cardiac and respiratory diseases. Epidemiology. 2010, 21: 414-423. 10.1097/EDE.0b013e3181d5c021.View ArticlePubMedGoogle Scholar
- Xu X, Li B, Huang H: Air pollution and unscheduled hospital outpatient and emergency room visits. Environ Health Perspect. 1995, 103: 286-289. 10.1289/ehp.95103286.View ArticlePubMedPubMed CentralGoogle Scholar
- Guo Y, Jia Y, Pan X, Liu L, Wichmann H: The association between fine particulate air pollution and hospital emergency room visits for cardiovascular diseases in Beijing, China. Sci Total Environ. 2009, 407: 4826-4830. 10.1016/j.scitotenv.2009.05.022.View ArticlePubMedGoogle Scholar
- Schwartz J, Marcus A: Mortality and air pollution in london: a time series analysis. Am J Epidemiol. 1990, 131: 185-194.PubMedGoogle Scholar
- Lee D, Shaddick G: Spatial modelling of air pollution in studies of its short-term health effects. Biometrics. 2010, 66: 1238-1246. 10.1111/j.1541-0420.2009.01376.x.View ArticlePubMedGoogle Scholar
- Prescott G, Cohen G, Elton R, Fowkes F, Agius R: Urban air pollution and cardiopulmonary ill health: a 14.5 year time series study. Occup Environ Med. 1998, 55: 697-704. 10.1136/oem.55.10.697.View ArticlePubMedPubMed CentralGoogle Scholar
- Carder M, McNamee R, Beverland I, Elton R, Van Tongeren M, Cohen G, Boyd J, MacNee W, Agius R: Interacting effects of air pollution and cold temperature on cardiorespiratory mortality in Scotland. Occup Environ Med. 2008, 65: 197-204. 10.1136/oem.2007.032896.View ArticlePubMedGoogle Scholar
- Dominici F, Daniels M, Zeger S, Samet J: Air pollution and mortality: estimating regional and national dose–response relationships. J Am Stat Assoc. 2002, 97: 100-111. 10.1198/016214502753479266.View ArticleGoogle Scholar
- Katsouyanni K, Touloumi G, Samoli E, Gryparis A, Le Tertre A, Monopolis Y, Rossi G, Zmirou D, Ballester F, Boumghar A, Anderson HR, Wojtyniak B, Paldy A, Braunstein R, Pekkanen J, Schindler C, Schwartz J: Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology. 2001, 12: 521-531. 10.1097/00001648-200109000-00011.View ArticlePubMedGoogle Scholar
- COMEAP: Cardiovascular Disease and Air Pollution. Department of Health report. 2006, : -.Google Scholar
- Shaddick G, Lee D, Zidek J, Salway R: Estimating exposure response function using ambient pollution concentrations. Annals of Applied Statistics. 2008, 2: 1249-1270.View ArticleGoogle Scholar
- Chang H, Peng R, Dominici F: Estimating the acute health effects of coarse particulate matter accounting for exposure measurement error. Biostatistics. 2011, 12: 637-652. 10.1093/biostatistics/kxr002.View ArticlePubMedPubMed CentralGoogle Scholar
- Chang H, Reich B, Miranda ML: Time-to-event analysis of fine particle air pollution and preterm birth: results from North Carolina, 2001–2005. American Journal of Epidemology. 2012, 175: 91-98. 10.1093/aje/kwr403.View ArticleGoogle Scholar
- Pope CA, Burnettt R, Turner M, Cohen A, Krewski D, Jerrett M, Gatstur S, Thun M: Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: shape of the exposure-response relationships. Environ Health Perspect. 2011, 119: 1616-1621. 10.1289/ehp.1103639.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/12/227/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.